We often experience science through the breakthrough announced in the news. But that moment comes at the end of a long and arduous process that often began years earlier. Understanding this journey, and the people who dedicate their careers to these efforts, can bring us one step closer to appreciating the value of that breakthrough. In the season finale of The Persistence Lab, a podcast from AbbVie, we revisit our conversations with the scientists and experts from this season to understand how optimism becomes a strategy to drive innovation, not just a mindset. Not intended for UK audiences.

For more information on AbbVie’s culture of scientific innovation, visit: https://www.abbvie.com/science/our-people.html.

Neurodegenerative diseases, like Alzheimer’s disease and Parkinson’s disease, are conditions that lead to a gradual, cumulative loss of neural activity in the brain. There are currently no cures for these conditions, and current care regimens focus on managing the symptoms of these diseases. In this episode, sponsored by AbbVie, we look at the impact of neurological conditions on patients and their families, and the persistence of the scientists and researchers who are exploring new clinical approaches that could potentially change the way these neurological conditions are treated. Not intended for UK audiences.

For more information on AbbVie’s efforts in neuroscience, visit: https://www.abbvie.com/science/areas-of-focus/neuroscience.html.

Why do some patients with autoimmune disease respond to treatment while others may not? Understanding these insights can offer scientists potential clues about the underlying cause of disease. This episode, sponsored by AbbVie, explores the approaches scientists use to help drive progress in immunology research like reverse translation – a process that works from “bedside to bench” using clinical observation and patient data to inform and refine drug development earlier on in the process. Not intended for UK audiences.

To learn more about AbbVie’s efforts in immunology, visit: https://www.abbvie.com/science/areas-of-focus/immunology.html